{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T19:06:03Z","timestamp":1785006363940,"version":"3.55.0"},"reference-count":35,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T00:00:00Z","timestamp":1587945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2016\/21\/N\/NZ5\/02584"],"award-info":[{"award-number":["2016\/21\/N\/NZ5\/02584"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Nonalcoholic fatty liver disease (NAFLD) is becoming a major public health problem worldwide. The study aimed to evaluate the concentration of eicosanoids in serum and liver tissue during steatosis progression and to assess whether eicosanoid change scores may predict liver tissue remodeling. Thirty six eight-week-old male Sprague Dawley rats were enrolled and sacrificed at different stages of NAFLD. Eicosanoid concentrations, namely lipoxin A4, hydroxyeicosatetraenoic acids (HETE), hydroxyloctadecadienoic acids (HODE), protectin DX, Maresine1, leucotriene B4, prostaglandin E2, and resolvin D1 measurement in serum and liver tissue with Agilent Technologies 1260 liquid chromatography were evaluated. For the liver and serum concentrations of 9-HODE and 13-HODE, the correlations were found to be strong and positive (r &gt; 0.7, p &lt; 0.05). Along with NAFLD progression, HODE concentration significantly increased, and change scores were more abundant in the liver. The moderate positive correlation between liver and serum (r = 0.52, p &lt; 0.05) was also observed for resolvin E1. The eicosanoid concentration decreased during NAFLD progression, but mostly in serum. There were significant correlations between HETE concentrations in liver and serum, but their associations were relatively low and changes the most in liver tissue. Eicosanoids profile, predominantly 9-HODE and 13-HODE, may serve as a potential biomarker for NAFLD development.<\/jats:p>","DOI":"10.3390\/molecules25092026","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T01:24:18Z","timestamp":1588123458000},"page":"2026","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Eicosanoids in Nonalcoholic Fatty Liver Disease (NAFLD) Progression. Do Serum Eicosanoids Profile Correspond with Liver Eicosanoids Content during NAFLD Development and Progression?"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2293-6489","authenticated-orcid":false,"given":"Dominika","family":"Maciejewska","sequence":"first","affiliation":[{"name":"Department of Human Nutrition and Metabolomics, Pomeranian Medical University in Szczecin, 70-204 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5816-2040","authenticated-orcid":false,"given":"Arleta","family":"Drozd","sequence":"additional","affiliation":[{"name":"Department of Human Nutrition and Metabolomics, Pomeranian Medical University in Szczecin, 70-204 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Skonieczna-\u017bydecka","sequence":"additional","affiliation":[{"name":"Department of Human Nutrition and Metabolomics, Pomeranian Medical University in Szczecin, 70-204 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3116-3115","authenticated-orcid":false,"given":"Marta","family":"Sk\u00f3rka-Majewicz","sequence":"additional","affiliation":[{"name":"Department of Human Nutrition and Metabolomics, Pomeranian Medical University in Szczecin, 70-204 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6116-4434","authenticated-orcid":false,"given":"Karolina","family":"Dec","sequence":"additional","affiliation":[{"name":"Department of Human Nutrition and Metabolomics, Pomeranian Medical University in Szczecin, 70-204 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5853-9709","authenticated-orcid":false,"given":"Karolina","family":"Jakubczyk","sequence":"additional","affiliation":[{"name":"Department of Human Nutrition and Metabolomics, Pomeranian Medical University in Szczecin, 70-204 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4955-4437","authenticated-orcid":false,"given":"Anna","family":"Pilutin","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology, Pomeranian Medical University in Szczecin, 70-204 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Stachowska","sequence":"additional","affiliation":[{"name":"Department of Human Nutrition and Metabolomics, Pomeranian Medical University in Szczecin, 70-204 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,4,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatol. Baltim. Md"},{"key":"ref_2","first-page":"9330","article-title":"Non-alcoholic fatty liver disease and obesity: Biochemical, metabolic and clinical presentations","volume":"20","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jhep.2006.06.013","article-title":"Hepatic histology in obese patients undergoing bariatric surgery","volume":"45","author":"Machado","year":"2006","journal-title":"J. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nm.4461","article-title":"The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis","volume":"24","author":"Ji","year":"2018","journal-title":"Nat. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1053\/j.gastro.2016.03.004","article-title":"Perspectives on treatment for nonalcoholic steatohepatitis","volume":"150","author":"Lassailly","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3748\/wjg.v25.i11.1307","article-title":"Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice","volume":"25","author":"Zhou","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), and European Association for the Study of Obesity (EASO) (2016). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J. Hepatol., 64, 1388\u20131402.","DOI":"10.1016\/j.jhep.2015.11.004"},{"key":"ref_8","first-page":"418","article-title":"Sampling error in histopathology findings of nonalcoholic fatty liver disease: A post mortem liver histology study","volume":"15","author":"Merat","year":"2012","journal-title":"Arch. Iran. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3109\/10715762.2012.677840","article-title":"Fatty liver induced by free radicals and lipid peroxidation","volume":"46","author":"Morita","year":"2012","journal-title":"Free Radic. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1476-4598-2-10","article-title":"Lipoxygenase and cyclooxygenase metabolism: New insights in treatment and chemoprevention of pancreatic cancer","volume":"2","author":"Ding","year":"2003","journal-title":"Mol. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2217\/clp.13.39","article-title":"Oxidized metabolites of linoleic acid as biomarkers of liver injury in nonalcoholic steatohepatitis","volume":"8","author":"Santoro","year":"2013","journal-title":"Clin. Lipidol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1194\/jlr.M007096","article-title":"Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"51","author":"Feldstein","year":"2010","journal-title":"J. Lipid Res."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Maciejewska, D., \u0141ukomska, A., Dec, K., Skonieczna-\u017bydecka, K., Gutowska, I., Sk\u00f3rka-Majewicz, M., Styburski, D., Misiakiewicz-Has, K., Pilutin, A., and Palma, J. (2019). Diet-Induced rat model of gradual development of non-alcoholic fatty liver disease (NAFLD) with lipopolysaccharides (LPS) secretion. Diagnostics, 9.","DOI":"10.3390\/diagnostics9040205"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s10620-009-0815-3","article-title":"Characterization of high-fat, diet-induced, non-alcoholic steatohepatitis with fibrosis in rats","volume":"55","author":"Xu","year":"2010","journal-title":"Dig. Dis. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatol. Baltim. Md"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/B978-0-12-404717-4.00005-6","article-title":"Eicosanoids in metabolic syndrome","volume":"Volume 66","author":"Hardwick","year":"2013","journal-title":"Advances in Pharmacology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nri3859","article-title":"Eicosanoid storm in infection and inflammation","volume":"15","author":"Dennis","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1194\/jlr.P055640","article-title":"Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis1","volume":"56","author":"Loomba","year":"2015","journal-title":"J. Lipid Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/hep.21763","article-title":"A lipidomic analysis of nonalcoholic fatty liver disease","volume":"46","author":"Puri","year":"2007","journal-title":"Hepatol. Baltim. Md"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Banaszczak, M., Maciejewska, D., Drozd, A., Ryterska, K., Milc, D.J., Raszeja-Wyszomirska, J., Wunsch, E., Gonz\u00e1lez-Muniesa, P., and Stachowska, E. (2020). 5-Lipooxygenase derivatives as serum biomarkers of a successful dietary intervention in patients with nonalcoholic fatty liver disease. Medicina (Mex.), 56.","DOI":"10.3390\/medicina56020058"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.prostaglandins.2012.06.001","article-title":"Lipidic last breath of life in patients with alcoholic liver disease","volume":"99","author":"Safranow","year":"2012","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1476-5381.1992.tb12789.x","article-title":"The role of endothelial cells in the relaxations induced by 13-hydroxy- and 13-hydroperoxylinoleic acid in canine arteries","volume":"107","author":"Bult","year":"1992","journal-title":"Br. J. Pharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/jlb.56.2.200","article-title":"13-HODE inhibits the intracellular calcium increase of activated human polymorphonuclear cells","volume":"56","author":"Engels","year":"1994","journal-title":"J. Leukoc. Biol."},{"key":"ref_24","first-page":"1","article-title":"Hepatic overproduction of 13-HODE due to ALOX15 upregulation contributes to alcohol-induced liver injury in mice","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/intimm\/dxz001","article-title":"Omega-3 fatty acid-derived mediators that control inflammation and tissue homeostasis","volume":"31","author":"Ishihara","year":"2019","journal-title":"Int. Immunol."},{"key":"ref_26","first-page":"3912","article-title":"Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation","volume":"178","author":"Arita","year":"2007","journal-title":"J. Immunol. Baltim. Md 1950"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1074\/jbc.M109.044131","article-title":"Resolvin E1 receptor activation signals phosphorylation and phagocytosis","volume":"285","author":"Ohira","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1084\/jem.20042031","article-title":"Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1","volume":"201","author":"Arita","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1096\/fj.08-125674","article-title":"Obesity-induced insulin resistance and hepatic steatosis are alleviated by \u03c9-3 fatty acids: A role for resolvins and protectins","volume":"23","author":"Horrillo","year":"2009","journal-title":"FASEB J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3892\/or.2015.4389","article-title":"Resolvin D1 and E1 alleviate the progress of hepatitis toward liver cancer in long-term concanavalin A-induced mice through inhibition of NF-\u03baB activity","volume":"35","author":"Kuang","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.metabol.2017.01.034","article-title":"Obesity is positively associated with arachidonic acid-derived 5- and 11-hydroxyeicosatetraenoic acid (HETE)","volume":"70","author":"Pickens","year":"2017","journal-title":"Metabolism"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.jdiacomp.2017.07.014","article-title":"Molecular mechanisms of nonalcoholic fatty liver disease: Potential role for 12-lipoxygenase","volume":"31","author":"Samala","year":"2017","journal-title":"J. Diabetes Complicat."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/hep.23229","article-title":"The Plasma Lipidomic Signature of Nonalcoholic Steatohepatitis","volume":"50","author":"Puri","year":"2009","journal-title":"Hepatol. Baltim. Md"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.4049\/jimmunol.0900327","article-title":"12\/15-Lipoxygenase counteracts inflammation and tissue damage in arthritis","volume":"183","author":"Katzenbeisser","year":"2009","journal-title":"J. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1089\/ars.2017.7332","article-title":"The eicosanoids, redox-regulated lipid mediators in immunometabolic disorders","volume":"29","author":"Wheelock","year":"2018","journal-title":"Antioxid. Redox Signal."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/9\/2026\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:51:23Z","timestamp":1760363483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/9\/2026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,27]]},"references-count":35,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,5]]}},"alternative-id":["molecules25092026"],"URL":"https:\/\/doi.org\/10.3390\/molecules25092026","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,27]]}}}